Armis Biopharma will be exhibiting its infection control products at the 2024 Chicago Midwinter Meeting.

Armis Biopharma Inc, a developer of solutions for infection control, will be exhibiting for the first time at the Chicago Dental Society’s 2024 Chicago Midwinter Meeting.

During the event, the company will be showcasing what it calls “The Trifecta of Dental Infection Control” that includes the following three products:

  • ArmiGard: Armis Biopharma’s flagship product is a non-toxic, non-corrosive solution formulated to remove 99% of odor-causing bacteria found on any oral appliance, device, denture, aligner, or CPAP. ArmiGard keeps any oral appliance clean, fresh, and clear without distortion, according to Armis.
  • ArmiCare: The lavender-scented hand sanitizer kills germs while keeping hands hydrated without being sticky or dry.
  • ArmiClenz: A multi-surface, multi-purpose disinfectant, sanitizer, and deodorizer that kills bacteria and 99% of the SARS-CoV-2 virus that causes COVID-19 and Human Rhinovirus 42 (the common cold), according to Armis.

ArmiGard and Armi Clenz both include a proprietary peracid/hydrogen peroxide-based non-systemic antimicrobial agent is designed to eliminate a number of bacterial, viral, and fungal threats.

“We’re very excited to leverage the success that Armis Biopharma has achieved in the medical industry and apply it to specific dental industry product applications,” said Michael Voss, Armis Biopharma’s chief commercial officer. “Our goal is to raise the bar on the efficacy and safety of commonly used products that sanitize oral appliances, hands, and surfaces. We also have another innovative dental product in development that we will introduce in the upcoming year.”

Photo courtesy of Armis Biopharma